By analyzing the genomes of thousands of patients' tumors, a research team has discovered many new cancer genes -- expanding the list of known genes tied to these cancers by 25 percent. The team's work, which lays a critical foundation for future cancer drug development, also shows that creating a comprehensive catalog of cancer genes for scores of cancer types is feasible with as few as 100,000 patient samples.